NCBI PubMed Centralopen access
AAV-based gene therapy with modified HEXB confers lasting therapeutic benefits in GM2 gangliosidosis models.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 223008
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.